287 related articles for article (PubMed ID: 24931587)
1. Exercise limitation of acetazolamide at altitude (3459 m).
Bradwell AR; Myers SD; Beazley M; Ashdown K; Harris NG; Bradwell SB; Goodhart J; Imray CH; Wimalasena Y; Edsell ME; Pattinson KT; Wright AD; Harris SJ;
Wilderness Environ Med; 2014 Sep; 25(3):272-7. PubMed ID: 24931587
[TBL] [Abstract][Full Text] [Related]
2. The effect of acetazolamide on saccadic latency at 3459 meters.
Faull OK; Robertson J; Thomas O; Bradwell AR; Antoniades CA; Pattinson KT;
Wilderness Environ Med; 2015 Mar; 26(1):72-7. PubMed ID: 25712298
[TBL] [Abstract][Full Text] [Related]
3. A dose-response study of acetazolamide for acute mountain sickness prophylaxis in vacationing tourists at 12,000 feet (3630 m).
Carlsten C; Swenson ER; Ruoss S
High Alt Med Biol; 2004; 5(1):33-9. PubMed ID: 15072715
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba and acetazolamide prophylaxis for acute mountain sickness: a randomized, placebo-controlled trial.
Chow T; Browne V; Heileson HL; Wallace D; Anholm J; Green SM
Arch Intern Med; 2005 Feb; 165(3):296-301. PubMed ID: 15710792
[TBL] [Abstract][Full Text] [Related]
5. Effects of acetazolamide on cognitive performance during high-altitude exposure.
Wang J; Ke T; Zhang X; Chen Y; Liu M; Chen J; Luo W
Neurotoxicol Teratol; 2013; 35():28-33. PubMed ID: 23280141
[TBL] [Abstract][Full Text] [Related]
6. Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent.
Toussaint CM; Kenefick RW; Petrassi FA; Muza SR; Charkoudian N
High Alt Med Biol; 2021 Mar; 22(1):5-13. PubMed ID: 32975448
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial.
Basnyat B; Gertsch JH; Johnson EW; Castro-Marin F; Inoue Y; Yeh C
High Alt Med Biol; 2003; 4(1):45-52. PubMed ID: 12713711
[TBL] [Abstract][Full Text] [Related]
8. Increased Cytokines at High Altitude: Lack of Effect of Ibuprofen on Acute Mountain Sickness, Physiological Variables, or Cytokine Levels.
Lundeberg J; Feiner JR; Schober A; Sall JW; Eilers H; Bickler PE
High Alt Med Biol; 2018 Sep; 19(3):249-258. PubMed ID: 29924642
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic low-dose acetazolamide reduces the incidence and severity of acute mountain sickness.
van Patot MC; Leadbetter G; Keyes LE; Maakestad KM; Olson S; Hackett PH
High Alt Med Biol; 2008; 9(4):289-93. PubMed ID: 19115912
[TBL] [Abstract][Full Text] [Related]
10. Acetazolamide improves cerebral oxygenation during exercise at high altitude.
Vuyk J; Van Den Bos J; Terhell K; De Bos R; Vletter A; Valk P; Van Beuzekom M; Van Kleef J; Dahan A
High Alt Med Biol; 2006; 7(4):290-301. PubMed ID: 17173514
[TBL] [Abstract][Full Text] [Related]
11. Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study.
Dehnert C; Böhm A; Grigoriev I; Menold E; Bärtsch P
Wilderness Environ Med; 2014 Sep; 25(3):263-71. PubMed ID: 24931591
[TBL] [Abstract][Full Text] [Related]
12. Peripheral arterial desaturation is further exacerbated by exercise in adolescents with acute mountain sickness.
Major SA; Hogan RJ; Yeates E; Imray CH
Wilderness Environ Med; 2012 Mar; 23(1):15-23. PubMed ID: 22441084
[TBL] [Abstract][Full Text] [Related]
13. Residence at Moderate Versus Low Altitude Is Effective at Maintaining Higher Oxygen Saturation During Exercise and Reducing Acute Mountain Sickness Following Fast Ascent to 4559 m.
Bernardi E; Pomidori L; Cavallari D; Mandolesi G; Cogo A
Wilderness Environ Med; 2017 Jun; 28(2):122-126. PubMed ID: 28455198
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Acetazolamide on Exercise Performance at Sea Level and in Hypoxic Environments: A Review.
Posch AM; Dandorf S; Hile DC
Wilderness Environ Med; 2018 Dec; 29(4):541-545. PubMed ID: 30314664
[TBL] [Abstract][Full Text] [Related]
15. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).
Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS
BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635
[TBL] [Abstract][Full Text] [Related]
16. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
Furian M; Mademilov M; Buergin A; Scheiwiller PM; Mayer L; Schneider S; Emilov B; Lichtblau M; Bitos K; Muralt L; Groth A; Reiser AE; Sevik A; Sheraliev U; Marazhapov NH; Aydaralieva S; Muratbekova A; Tabyshova A; Abdraeva A; Buenzli S; Sooronbaev TM; Ulrich S; Bloch KE
NEJM Evid; 2022 Jan; 1(1):EVIDoa2100006. PubMed ID: 38296630
[TBL] [Abstract][Full Text] [Related]
17. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
Berger MM; Sareban M; Schiefer LM; Swenson KE; Treff F; Schäfer L; Schmidt P; Schimke MM; Paar M; Niebauer J; Cogo A; Kriemler S; Schwery S; Pickerodt PA; Mayer B; Bärtsch P; Swenson ER
J Appl Physiol (1985); 2022 Jun; 132(6):1361-1369. PubMed ID: 35511718
[TBL] [Abstract][Full Text] [Related]
18. Intraocular pressure is not associated with acute mountain sickness.
Cushing T; Paterson R; Haukoos J; Harris NS
High Alt Med Biol; 2013 Dec; 14(4):342-5. PubMed ID: 24377341
[TBL] [Abstract][Full Text] [Related]
19. Effect of acetazolamide on leg endurance exercise at sea level and simulated altitude.
Fulco CS; Muza SR; Ditzler D; Lammi E; Lewis SF; Cymerman A
Clin Sci (Lond); 2006 Jun; 110(6):683-92. PubMed ID: 16499476
[TBL] [Abstract][Full Text] [Related]
20. Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo-Controlled Trial of Acetazolamide.
Latshang TD; Kaufmann B; Nussbaumer-Ochsner Y; Ulrich S; Furian M; Kohler M; Thurnheer R; Saguner AM; Duru F; Bloch KE
Sleep; 2016 Sep; 39(9):1631-7. PubMed ID: 27306264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
